2-174750143-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP3BS1_Supporting
The NM_000079.4(CHRNA1):c.805G>C(p.Val269Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000441 in 1,608,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000079.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNA1 | NM_000079.4 | c.805G>C | p.Val269Leu | missense_variant | Exon 7 of 9 | ENST00000348749.9 | NP_000070.1 | |
CHRNA1 | NM_001039523.3 | c.880G>C | p.Val294Leu | missense_variant | Exon 8 of 10 | NP_001034612.1 | ||
CHRNA1 | XM_017003256.2 | c.901G>C | p.Val301Leu | missense_variant | Exon 7 of 9 | XP_016858745.1 | ||
CHRNA1 | XM_017003257.2 | c.826G>C | p.Val276Leu | missense_variant | Exon 6 of 8 | XP_016858746.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000189 AC: 28AN: 148452Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250270Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135334
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1460066Hom.: 0 Cov.: 34 AF XY: 0.0000220 AC XY: 16AN XY: 726362
GnomAD4 genome AF: 0.000188 AC: 28AN: 148566Hom.: 0 Cov.: 31 AF XY: 0.000152 AC XY: 11AN XY: 72272
ClinVar
Submissions by phenotype
Lethal multiple pterygium syndrome Uncertain:2
This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 269 of the CHRNA1 protein (p.Val269Leu). This variant is present in population databases (no rsID available, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with CHRNA1-related conditions. ClinVar contains an entry for this variant (Variation ID: 892724). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CHRNA1 protein function with a negative predictive value of 80%. This variant disrupts the p.Val269 (also known as p.Val249) amino acid residue in CHRNA1. Other variant(s) that disrupt this residue have been observed in individuals with CHRNA1-related conditions (PMID: 9221765, 33216040), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Congenital myasthenic syndrome Uncertain:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at